[1]冯彦林,谭家驹,梁生,等.[188Re(CO)3(H2O)3]+间接标记免疫磁性纳米微粒的实验研究[J].国际放射医学核医学杂志,2007,31(4):211-214.
 FENG Yan-lin,TAN Jia-ju,LIANG Sheng,et al.Labeling of immuno-magnetic nanoparticle with[188Re(CO)3(H2O)3]+[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):211-214.
点击复制

[188Re(CO)3(H2O)3]+间接标记免疫磁性纳米微粒的实验研究(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第4期
页码:
211-214
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Labeling of immuno-magnetic nanoparticle with[188Re(CO)3(H2O)3]+
作者:
冯彦林1 谭家驹1 梁生2 孙静1 吴校连1 司建华1 夏姣云2 温广华1
1. 528000 广东佛山, 中山大学附属佛山医院(佛山市第一人民医院)核医学科;
2. 200000 上海, 中国科学院应用物理研究所
Author(s):
FENG Yan-lin1 TAN Jia-ju1 LIANG Sheng2 SUN Jing1 WU Xiao-lian1 Si Jian-hua1 XIA Jiao-yun2 WEN Guang-hua1
1. Department of Nuclear Medcine, AfflUaed Foshan Hospital of Sun Yat-Sen University and The First People’s Hospital of Foshan, Foshan 528000, China;
2. Shanhai Institute of Applied Physics, Chinses Academy of Sciences, Shanhai 201800, China
关键词:
同位素标记螯合剂磁性纳米微粒
Keywords:
Isotope labelingRheniumChelating agentsSuperparamagnetic nanoparticles
分类号:
R817.4
摘要:
目的 探讨标记单克隆抗体磁性纳米微粒的实验条件。方法 以[二(2-吡啶甲基)-氨基]-乙酸(PADA)作为双功能螯合剂,将[188Re(CO)3(H2O)3]+间接标记到耦联了单克隆抗体的磁性纳米微粒。结果 [188Re(CO)3(H2O)3]+间接标记免疫磁性纳米微粒的标记率大于80%,在小牛血清和生理盐水中48 h后稳定性仍能保持在90%以上。结论 使用PADA作为双功能螯合剂,[188Re(CO)3(H2O)3]+间接标记免疫磁性纳米微粒的标记率高,稳定性好,适于进一步体内研究。
Abstract:
Objective To investigate a fine experiment condition of indirect labeling method that Hepama-1-SPIONs(supeiparamagnetic iron oxide nanoparticles)was labelled with rhenium-188 complex([188Re(CO)3(H2O)3]+). Methods The Hepama-1-SPIONs bridged by bifunctional chelating agent 2-picolylamine-N,N-diacetic acid(PADA) was labelled rhenium-188-tricarbonyl complex prepared with high labeling yields. Results The labeling rate of [188Re(CO)3(H2O)3]+-PADA-Hepama-1-SPIONs was more than 80%, and was extremely stable in vitro, The labeling rate of 188Re-(CO)3(H2O)3-PADA-Hepama-1-SPIONs was more than 90% after 48 in calf serum and isotonic Na chloride. Conclusions 188Re-(CO)3(H2O)3-PADA-Hepama-1-SPIONs shows it’s fine stability and biological properties, and it is well worth further researching as bio-magnetically targeted radiotherapy for cancer.

参考文献/References:

1 谭家驹,张阳德,冯彦林,等. 一种新型生物-磁双重靶向纳米材料的制备.中国医学工程杂志,2007,15(5):387-391.
2 冯彦林,谭家驹,张春富,等. 肿瘤靶向治疗用白蛋白磁性纳米粒子的~(188)铼(~(188)Re)标记(英文).中国医学工程杂志,2003,11(6):5-8.
3 谭家驹,张春富,冯彦林. 靶向治疗用Fe3O4及其白蛋白包被磁性纳米粒子的制备(英文).中国医学工程杂志,2003,11(06):30-32.
4 Robinson MK,Weiner LM,Adams GP. Improving monoclonal antibodies for cancer therapy. Drug Develop Res,2004,61(03):172-187.
5 Najafi A,Alauddin MM,Sosa A. The evaluation of 186Re-labeled antibodies using N2S2 chelate in vitro and in vivo using tumor-bearing nude mice.Nucl Med Biol,1992,19(3):202-205.
6 Visser GWM,Gerrretsen M,Herscheid JDM. Labeling of monoclonal antivodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer:A technical protocol.J Nucl Med,1993,34(11):1953-1962.
7 贾芳,孟昭兴,胡久华,等. 188Re间接标记单克隆抗体的研究.核技术,2001,24(08):716-719.
8 Gog FB,Visser GWM,Klok R. Monoclonal antibodies labelled with rhenium-186 using the MAG3 chelate:Relatioship between the number of chelated groups and biodistrivution characteristics.J Nucl Med,1996,37(02):352-362.
9 Waibel R,Alberto R,Willuda J. Stable one-step technetium-99m labeling of his-tagged recombinant proteins with a novel Tc(Ⅰ)-carbonylcomplex.Nat Biotechnol,1999,17(9):897-901.
10 Willuda J,Honegger A,Waibel R. High thermal stability is essential for tumor targeting of antibody fragments:engineering of a humanized anti-epithelial glycoprotein-2(epithelial cell adhesion molecule) single-chain Fv fragment.Cancer Res,1999,59(22):5758-5767.
11 Murray A,Scholfield DP,Schibli R,et al. A preliminary comparison of methods for production of 188Re-C595 antibodies for radioimmunot-herapy of bladder cancer.J Label Compd Radiopharm,2001,44(Suppl):S573-S575.

相似文献/References:

[1]解朋,黄建敏,张芳,等.99Tcm-MAG3-isoDGR-2C分子探针的制备与体内分布的实验研究[J].国际放射医学核医学杂志,2016,40(5):345.[doi:10.3760/cma.j.issn.1673-4114.2016.05.004]
 Xie Peng,Huang Jianmin,Zhang Fang,et al.Labeling MAG3-isoDGR-2C with 99Tcm and its biodistribution in mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):345.[doi:10.3760/cma.j.issn.1673-4114.2016.05.004]
[2]夏伟,吕中伟,王国玉,等.99Tcm标记depreotide及与肺腺癌A549细胞亲和性研究[J].国际放射医学核医学杂志,2010,34(4):193.[doi:10.3760/cma.j.issn.1673-4114.2010.04.001]
 XIA Wei,LÜ,Zhong-wei,et al.Experimental studies of depreotide labeled with 99Tcm and the affinity with human lung adenocarcinoma cell line A549[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):193.[doi:10.3760/cma.j.issn.1673-4114.2010.04.001]
[3]朱沭,赵明,陈璟.核酸及其类似物的常见放射性核素标记及显像[J].国际放射医学核医学杂志,2011,35(1):44.[doi:10.3760/cma.j.issn.1673-4114.2011.01.013]
 ZHU Shu,ZHAO Ming,CHEN Jing.Radionuclide labeling and imaging nucleic acids and its analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):44.[doi:10.3760/cma.j.issn.1673-4114.2011.01.013]
[4]洪智慧,周小林,石怡珍,等.131I标记抗胃泌素释放前体单链抗体的制备及其稳定性和免疫活性研究[J].国际放射医学核医学杂志,2010,34(2):107.[doi:10.3760/cma.j.issn.1673-4114.2010.02.013]
 HONG Zhi-hui,ZHOU Xiao-lin,SHI Yi-zhen,et al.Preparation and evaluation of 131I-anti-ProGRP(31-98) single-chain antibody fragment[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):107.[doi:10.3760/cma.j.issn.1673-4114.2010.02.013]
[5]刘键,张现忠,张仕坚,等.99Tcm标记双膦酸盐骨显像剂的研究进展[J].国际放射医学核医学杂志,2009,33(5):296.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.013]
 LIU Jian,ZHA NG Xian-zhong,ZHA NG Shi-jian,et al.The new advanced of 99Tcm-labeled bisphosphonates as bone scintigraphy agent[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):296.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.013]
[6]邓胜明,张玮,章斌,等.188Re-胰岛素样生长因子1类似物在荷人胰腺癌裸鼠体内分布及其显像研究[J].国际放射医学核医学杂志,2008,32(3):129.
 DENG Sheng-ming,ZHANG Wei,ZHANG Bin,et al.Studies on biodistribution and imaging of 188Re labeled insulin-like growth factor-1 analogue in nude mice bearing human pancreatic carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):129.
[7]蒋宁一,熊玥.放射免疫导向治疗真菌感染灶的研究[J].国际放射医学核医学杂志,2008,32(3):137.
 JIANG Ning-yi,XIONG Yue.Research about the radioimmunotherapy of fungal infection[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):137.
[8]李楠,李培勇.放射性碘间接标记抗体方法的研究进展[J].国际放射医学核医学杂志,2008,32(5):260.
 LI Nan,LI Pei-yong.The recent development of the strategy for indirect antibody radiolabel with iodine[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):260.
[9]武明芬,王荣先,尹鹏.18F标记的非天然氨基酸PET显像剂[J].国际放射医学核医学杂志,2008,32(4):202.
 WU Ming-fen,WA NG Rong-xian,YIN Peng.PET imaging agent of 18F lablled non-natrual animo acid[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):202.
[10]冯彦林,谭家驹,梁生,等.抗人肝癌188Re-免疫磁性纳米微粒的生物学分布和肿瘤细胞抑制实验[J].国际放射医学核医学杂志,2007,31(6):321.
 FENG Yan-lin,TAN Jia-jü,LIANG Sheng,et al.Experimental study of the biological properties of 188Re-Hepama-1 biologic superparamagnetic nanoparticles[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):321.

备注/Memo

备注/Memo:
收稿日期:2006-12-17。
通讯作者:冯彦林(E-mail:fylin@fsyyy.com)
更新日期/Last Update: 1900-01-01